title: Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
abstract: Thirty-two seronegative pups were vaccinated at 8 weeks of age with modified-live canine distemper virus (CDV), canine adenovirus type-2 (CAV-2), and canine parvovirus (CPV) vaccine and at 12 weeks with a modified-live CDV, CAV-2, CPV, and killed rabies virus vaccine. An additional 31 seronegative pups served as age-matched, nonvaccinated controls. All test dogs were strictly isolated for 3 years after receiving the second vaccination and then were challenged with virulent rabies virus. Clinical signs of rabies were prevented in 28 (88%) of the 32 vaccinated dogs. In contrast, 97% (30 of 31) of the control dogs died of rabies infection. These study results indicated that no immunogenic interference occurred between the modified-live vaccine components and the killed rabies virus component. Furthermore, these results indicated that the rabies component in the test vaccine provided protection against virulent rabies challenge in dogs 12 weeks of age or older for a minimum of 3 years following vaccination.
authors.affiliation: Intervet Inc., 29160 Intervet Lane, Millsboro, DE 19966, USA.
authors.forename: Nallakannu
authors.initials: N
authors.lastname: Lakshmanan
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Gore
authors.forename: Karen L
authors.initials: KL
authors.lastname: Duncan
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Coyne
authors.forename: Melissa A
authors.initials: MA
authors.lastname: Lum
authors.forename: Frank J
authors.initials: FJ
authors.lastname: Sterner
mesh_terms: D000256:Adenoviridae / Q000276:immunology; D000257:Adenoviridae Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D000818:Animals; D004216:Distemper / Q000276:immunology / Q000517:prevention & control*; D004217:Distemper Virus, Canine / Q000276:immunology; D004283:Dog Diseases / Q000276:immunology / Q000517:prevention & control*; D004285:Dogs; D005260:Female; D008297:Male; D010322:Parvoviridae Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D017993:Parvovirus, Canine / Q000276:immunology; D011818:Rabies / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D011819:Rabies Vaccines; D011820:Rabies virus / Q000276:immunology; D013997:Time Factors; D014611:Vaccination / Q000662:veterinary; D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated; D014765:Viral Vaccines / Q000276:immunology*
chemical_list: D011819:Rabies Vaccines; D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated; D014765:Viral Vaccines